Hematologic Malignancies

2 researchers across 2 institutions

2 Researchers
2 Institutions
1 Grant PIs
0 High Impact

Research in hematologic malignancies investigates the complex biological processes that drive cancers of the blood, bone marrow, and lymph nodes. Scientists explore the molecular mechanisms underlying the development and progression of diseases such as leukemia, lymphoma, and myeloma. This work involves analyzing genetic mutations, cellular signaling pathways, and the tumor microenvironment. Methodologies include advanced genomic sequencing, cell culture models, bioinformatics, and preclinical studies to identify new therapeutic targets and understand disease resistance.

Given Arkansas's health landscape, research in hematologic malignancies holds significant relevance. Understanding the incidence and unique characteristics of these cancers within the state's population can inform public health strategies and improve patient outcomes. This work may also identify opportunities for developing new diagnostic tools and treatments, potentially fostering growth in the state's biotechnology and healthcare sectors.

This research area benefits from strong connections to fields including cancer-related molecular mechanisms, metabolism and genetic disorders, and cancer treatment and pharmacology. Expertise spans multiple institutions across Arkansas, fostering collaborative approaches to understanding and combating these diseases.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Pamela Lockyer UAMS 19 1,429 Grants
Sepideh Shakeri University of Arkansas 16 1,011
Cancer-Related Molecular Mechanisms Research 2 Metabolism And Genetic Disorders 2 Myelodysplastic Syndromes 1 Chronic Myelomonocytic Leukemia 1 Disease Mechanisms Research 1 Cancer Treatment And Pharmacology 1 Molecular Biology Techniques And Applications 1 Acute Lymphoblastic Leukemia Research 1 Mitochondrial Function And Pathology 1 Medical Imaging Techniques And Applications 1 Retrospective Studies 1

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
3,650 works in 2026
-3.2% CAGR 2018–2026
Leadership concentration
10.1% held by global top 5 institutions
Moderate HHI 69
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2026 window.

Top US institutions in this area

  1. 1 Fred Hutch Cancer Center 4,360
  2. 2 The University of Texas MD Anderson Cancer Center 2,641
  3. 3 University of Washington 2,607
  4. 4 University of Minnesota 2,333
  5. 5 Dana-Farber Cancer Institute 2,310

Researchers with Federal Grants

Pamela Lockyer UAMS 1 grant
Browse All 2 Researchers in Directory